The Procter & Gamble Company (NYSE:PG – Free Report) – Investment analysts at Zacks Research reduced their FY2025 earnings estimates for shares of Procter & Gamble in a note issued to investors on Wednesday, May 7th. Zacks Research analyst R. Lohia now expects that the company will post earnings per share of $6.77 for the year, down from their previous forecast of $6.92. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.91 per share. Zacks Research also issued estimates for Procter & Gamble’s Q1 2026 earnings at $1.90 EPS, Q2 2026 earnings at $1.94 EPS, Q3 2026 earnings at $1.59 EPS, Q4 2026 earnings at $1.54 EPS, FY2026 earnings at $6.97 EPS, Q1 2027 earnings at $2.06 EPS, Q2 2027 earnings at $2.08 EPS, Q3 2027 earnings at $1.68 EPS and FY2027 earnings at $7.46 EPS.
Several other brokerages have also recently weighed in on PG. Citigroup reduced their price target on shares of Procter & Gamble from $200.00 to $181.00 and set a “buy” rating on the stock in a research report on Friday, April 25th. UBS Group restated a “buy” rating on shares of Procter & Gamble in a research report on Monday, February 10th. Erste Group Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Morgan Stanley set a $180.00 price target on Procter & Gamble and gave the stock an “overweight” rating in a research report on Friday, April 25th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $181.00 to $172.00 and set an “overweight” rating on the stock in a research note on Friday, April 11th. Eight equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $178.52.
Procter & Gamble Trading Down 0.6 %
Shares of Procter & Gamble stock opened at $157.73 on Friday. The business has a 50-day moving average price of $165.92 and a 200-day moving average price of $167.57. Procter & Gamble has a twelve month low of $156.58 and a twelve month high of $180.43. The firm has a market cap of $369.80 billion, a price-to-earnings ratio of 25.12, a PEG ratio of 3.76 and a beta of 0.41. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same period in the previous year, the business earned $1.52 earnings per share. The business’s revenue was down 2.1% on a year-over-year basis.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Monday, April 21st will be issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.68%. The ex-dividend date of this dividend is Monday, April 21st. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.01. Procter & Gamble’s dividend payout ratio is currently 66.98%.
Insider Buying and Selling
In related news, insider Moses Victor Javier Aguilar sold 10,520 shares of the company’s stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the transaction, the insider now directly owns 25,182 shares of the company’s stock, valued at $3,995,627.94. This represents a 29.47 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 35,000 shares of Procter & Gamble stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $173.68, for a total value of $6,078,800.00. Following the sale, the chief executive officer now directly owns 22,051 shares of the company’s stock, valued at approximately $3,829,817.68. This represents a 61.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 64,520 shares of company stock worth $10,999,268 in the last ninety days. 0.18% of the stock is owned by insiders.
Institutional Trading of Procter & Gamble
Hedge funds and other institutional investors have recently made changes to their positions in the business. Lakeridge Wealth Management LLC grew its holdings in Procter & Gamble by 0.6% during the fourth quarter. Lakeridge Wealth Management LLC now owns 10,807 shares of the company’s stock worth $1,812,000 after acquiring an additional 60 shares during the period. Unique Wealth LLC grew its stake in shares of Procter & Gamble by 2.9% during the 1st quarter. Unique Wealth LLC now owns 2,141 shares of the company’s stock worth $365,000 after purchasing an additional 61 shares during the period. Stableford Capital II LLC increased its holdings in shares of Procter & Gamble by 1.1% during the 1st quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock valued at $993,000 after purchasing an additional 61 shares in the last quarter. Colton Groome Financial Advisors LLC boosted its holdings in Procter & Gamble by 3.2% during the fourth quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company’s stock worth $334,000 after buying an additional 62 shares in the last quarter. Finally, Bernard Wealth Management Corp. grew its position in Procter & Gamble by 20.2% during the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company’s stock valued at $64,000 after buying an additional 63 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Growth Stocks: What They Are, Examples and How to Invest
- Google Is Betting Big on Nuclear Reactors—Should You?
- Earnings Per Share Calculator: How to Calculate EPS
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Growth Stocks: What They Are, What They Are Not
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.